Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 411376011000036111 | aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 411378011000036110 | aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL oral liquid, 5 mL measure (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | Is a | aluminium hydroxide + magnesium hydroxide + simethicone | true | Inferred relationship | Some | ||
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has intended active ingredient | aluminium hydroxide | true | Inferred relationship | Some | 577941504 | |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has Australian BoSS | aluminium hydroxide | true | Inferred relationship | Some | 577941504 | |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has intended active ingredient | magnesium hydroxide | true | Inferred relationship | Some | 377200832 | |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has Australian BoSS | magnesium hydroxide | true | Inferred relationship | Some | 377200832 | |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has intended active ingredient | simethicone | true | Inferred relationship | Some | 379139072 | |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has Australian BoSS | simethicone | true | Inferred relationship | Some | 379139072 | |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has manufactured dose form | oral liquid | true | Inferred relationship | Some | ||
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | has unit of use | measure | true | Inferred relationship | Some | 577941505 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mylanta Double Strength reformulation oral liquid, 5 mL | Is a | True | aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | Inferred relationship | Some | |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid, 200 mL | has MPUU | True | aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | Inferred relationship | Some | 1 |
| aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid, 500 mL | has MPUU | True | aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR